Biobanking Clinical Trials
Clinical Trials involving Novel Treatments of CLL
- Acalabrutinib, Obinutuzumab, and Venetoclax for initial therapy of CLL (AVO)
- Duvelisib and Venetoclax for Relapsed or Refractory CLL or SLL
- A Study of Ibrutinib and Obinutuzumab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
- A Study comparing BGB-3111 with Bendamustine with Rituxumab in Patients with previously Untreated CLL or SLL
- Safety and Efficacy of KTE-C19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia (ZUMA-8)
- Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma